Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dare Bioscience, Inc.DARE · Entity 7799 | Director | June 13, 2019 | June 14, 2019 |
| ZOGENIX, INC.ZGNX · Entity 129305 | Director | March 29, 2019 | April 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dare Bioscience, Inc.
Report date June 13, 2019 · Filed June 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.90 · Expires 2029-06-13 | Direct | 22,500 |
Reported balance
After 2019-06-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-13 · Grant · Acquired 22,500 · Balance 22,500 F1: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.
ZOGENIX, INC.
Report date March 29, 2019 · Filed April 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,575 |
Ending reported balance
After 2019-03-29 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2019-03-29 · Exercise / conversion · Acquired 5,000 · Balance 15,575 Row 2 · 2019-03-29 · Sale · Disposed 5,000 · Balance 10,575 F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Row 3 · 2019-03-29 · Exercise / conversion · Acquired 15,700 · Balance 26,275 Row 4 · 2019-03-29 · Sale · Disposed 15,700 · Balance 10,575 F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.00 · Expires 2019-09-01 | Direct | 2,500 |
Reported balance
After 2019-03-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-29 · Exercise / conversion · Disposed 5,000 · Balance 2,500 F2: The Option was granted on September 1, 2009 and vests in a series of twenty-four (24) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.92 · Expires 2021-03-01 | Direct | 20,624 |
Reported balance
After 2019-03-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-29 · Exercise / conversion · Disposed 15,700 · Balance 20,624 F3: The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The Option was granted on September 1, 2009 and vests in a series of twenty-four (24) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
F3: The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2019 Filed Jun 14, 2019 11:01 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001257386-19-000007 · wf-form4_156051008272911.xml · derivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| April 11, 2019 Filed Apr 15, 2019 20:25 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | PurchaseCommon stock | 454,545 | $1.10 | $499,999.50 |
DisclosureSEC source: 0001257386-19-000005 · wf-form4_155535993775373.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 944,956 F1 · security: The reported securities were purchased by the reporting person in the underwritten public offering of the issuer which closed on April 11, 2019. The reported securities are held in The Hawley Family Trust Dated October 22, 2004, of which the reporting person is the trustee. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,700 | $0.00 Strike: $33.92 | $0.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · derivative · entry 6 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,624 Underlying: Common Stock · 15,700 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · derivative · entry 5 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 5,000 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option was granted on September 1, 2009 and vests in a series of twenty-four (24) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 15,700 | $55.00 | $863,500.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · nonDerivative · entry 4 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 F1 · acquired: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 15,700 | $33.92 | $532,544.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · nonDerivative · entry 3 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 5,000 | $55.00 | $275,000.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 F1 · acquired: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 17:12 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001375151-19-000048 · wf-form4_155423952274020.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 17:21 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 38,789 | $52.93 | $2,053,260.80 |
DisclosureSEC source: 0001375151-19-000026 · wf-form4_155268488209948.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575 F2 · price: The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $52.7692 to $53.3050, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 17:21 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 21,211 | $53.10 | $1,126,215.01 |
DisclosureSEC source: 0001375151-19-000026 · wf-form4_155268488209948.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,364 F1 · price: The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $53.00 to $53.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,175 | $0.00 Strike: $33.92 | $0.00 |
DisclosureSEC source: 0001375151-19-000020 · wf-form4_155182024730595.xml · derivative · entry 5 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,325 Underlying: Common Stock · 1,175 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001375151-19-000020 · wf-form4_155182024730595.xml · derivative · entry 4 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 3,125 shares Expires 2020-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Option was granted on May 25, 2010 and 1/4 of the total number of shares of common stock subject to the option vest on May 25, 2011, and 1/48th of the total remaining number of shares of common stock subject to the Option vest monthly thereafter, subject tothe Reporting Person's continued employment or service relationship on each vesting date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 4,300 | $50.00 | $215,000.00 |
DisclosureSEC source: 0001375151-19-000020 · wf-form4_155182024730595.xml · nonDerivative · entry 3 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,575 F1 · acquired: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 1,175 | $33.92 | $39,856.00 |
DisclosureSEC source: 0001375151-19-000020 · wf-form4_155182024730595.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:11 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 3,125 | $32.00 | $100,000.00 |
DisclosureSEC source: 0001375151-19-000020 · wf-form4_155182024730595.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 7, 2019 17:14 UTC Amendment | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,175 | $0.00 Strike: $33.92 | $0.00 |
DisclosureSEC source: 0001375151-19-000022 · wf-form4a_155199687046526.xml · derivative · entry 5 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,325 Underlying: Common Stock · 1,175 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The Option was granted on March 1, 2011 and vests in a series of forty-eight (48) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. Read SEC document |
| March 01, 2019 Filed Mar 7, 2019 17:14 UTC Amendment | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001375151-19-000022 · wf-form4a_155199687046526.xml · derivative · entry 4 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 3,125 shares Expires 2020-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Option was granted on May 25, 2010 and 1/4 of the total number of shares of common stock subject to the option vest on May 25, 2011, and 1/48th of the total remaining number of shares of common stock subject to the Option vest monthly thereafter, subject tothe Reporting Person's continued employment or service relationship on each vesting date. Read SEC document |
| March 01, 2019 Filed Mar 7, 2019 17:14 UTC Amendment | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 4,300 | $55.00 | $236,500.00 |
DisclosureSEC source: 0001375151-19-000022 · wf-form4a_155199687046526.xml · nonDerivative · entry 3 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,575 F2 · price: The purpose of this Amendment is to correct the Price of the Securities Disposed. There are no other changes to the original filing, including the transaction listed herein. F1 · acquired: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 01, 2019 Filed Mar 7, 2019 17:14 UTC Amendment | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 1,175 | $33.92 | $39,856.00 |
DisclosureSEC source: 0001375151-19-000022 · wf-form4a_155199687046526.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 7, 2019 17:14 UTC Amendment | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 3,125 | $32.00 | $100,000.00 |
DisclosureSEC source: 0001375151-19-000022 · wf-form4a_155199687046526.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 20,000 | $41.35 | $826,910.00 |
DisclosureSEC source: 0001375151-18-000089 · wf-form4_154508120130169.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,575 F1 · price: The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $41.31 to $41.54, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 21:52 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-042387 · doc4.xml · derivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-07-10 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 22:30 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | PurchaseCommon stock | 140,000 | $1.45 | $203,378.00 |
DisclosureSEC source: 0001209191-18-037306 · doc4.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · price: The price reported is a weighted average. This transaction was executed in multiple trades at prices ranging from $1.385 to $1.48. The reporting person undertakes to provide full information regarding the number of shares and prices at which the trades were effected upon request to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission. Read SEC document |
| May 23, 2018 Filed May 24, 2018 18:36 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $41.68 | $0.00 |
DisclosureSEC source: 0001375151-18-000045 · wf-form4_152720135807792.xml · derivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-05-22 F1 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F2 · derivative.exercise_date: The option was granted on May 23, 2018, the date of the Company's Annual Meeting of Stockholders, and vests in twelve (12) equal monthly installments from the grant date such that the option is fully vested on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Company on each vesting date. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · derivative · entry 12 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on May 23, 2017 and vests in a series of twelve (12) successive, equal monthly installments beginning on May 23, 2017, subject to the Reporting Person's continued service to the company on each vesting date. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,953 | $0.00 Strike: $10.64 | $0.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · derivative · entry 11 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,464 Underlying: Common Stock · 1,953 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted on March 17, 2015 and vested in a series of forty-eight (48) successive, equal monthly installments beginning on March 17, 2015, subject to the Reporting Person's continued employment with or service to the company on each such vesting date. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,798 | $0.00 Strike: $15.04 | $0.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · derivative · entry 10 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,663 Underlying: Common Stock · 16,798 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on April 27, 2012 and vested in a series of forty-eight (48) successive, equal monthly installments beginning on April 27, 2012, subject to the Reporting Person's continued employment with or service to the company on each vesting date. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,009 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · derivative · entry 9 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,009 shares Expires 2018-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Option was granted on October 21, 2008 and 1/4 of the total number of shares of common stock subject to the option vested on October 21, 2009, and 1/48th of the total remaining number of shares of common stock subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment or service relationship on each such vesting date. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 27,760 | $44.65 | $1,239,436.81 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 7 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.20, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 5,000 | $12.75 | $63,750.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 6 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 1,953 | $10.64 | $20,779.92 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 5 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 16,798 | $15.04 | $252,641.92 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 4 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 4,009 | $28.00 | $112,252.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 3 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,240 | $0.00 Strike: $28.00 | $0.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · derivative · entry 8 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 Underlying: Common Stock · 7,240 shares Expires 2018-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Option was granted on October 21, 2008 and 1/4 of the total number of shares of common stock subject to the option vested on October 21, 2009, and 1/48th of the total remaining number of shares of common stock subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment or service relationship on each such vesting date. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 7,240 | $44.97 | $325,549.50 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 2 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.85 to $45.05, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 16:15 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 7,240 | $28.00 | $202,720.00 |
DisclosureSEC source: 0001375151-18-000010 · wf-form4_152105852006937.xml · nonDerivative · entry 1 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 24 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option was granted on May 23, 2017 and vests in a series of twelve (12) successive, equal monthly installments beginning on May 23, 2017, subject to the Reporting Person's continued service to the company on each vesting date. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,462 | $0.00 Strike: $10.64 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 23 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417 Underlying: Common Stock · 8,462 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted on March 17, 2015 and vested in a series of forty-eight (48) successive, equal monthly installments beginning on March 17, 2015, subject to the Reporting Person's continued employment with or service to the company on each such vesting date. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 44,741 | $0.00 Strike: $15.04 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 22 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,461 Underlying: Common Stock · 44,741 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on April 27, 2012 and vested in a series of forty-eight (48) successive, equal monthly installments beginning on April 27, 2012, subject to the Reporting Person's continued employment with or service to the company on each vesting date. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 10,000 | $36.84 | $368,407.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 16 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $36.90, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 10,000 | $12.75 | $127,500.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 15 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 8,462 | $36.84 | $311,746.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 14 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $36.90, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 8,462 | $10.64 | $90,035.68 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 13 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 44,741 | $36.84 | $1,648,289.76 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 12 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $36.90, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 44,741 | $15.04 | $672,904.64 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 11 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,797 | $0.00 Strike: $15.04 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 21 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,202 Underlying: Common Stock · 11,797 shares Expires 2022-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on April 27, 2012 and vested in a series of forty-eight (48) successive, equal monthly installments beginning on April 27, 2012, subject to the Reporting Person's continued employment with or service to the company on each vesting date. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | SaleCommon Stock | 11,797 | $37.02 | $436,703.71 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 10 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,575 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.05, inclusive. The Reporting Person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionCommon Stock | 11,797 | $15.04 | $177,426.88 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · nonDerivative · entry 9 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 20 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on July 13, 2016 and vested in a series of twelve (12) successive, equal monthly installments beginning on August 1, 2016, subject to the Reporting Person's continued service to the company on each vesting date. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 20:13 UTC | ZOGENIX, INC. ZGNX · Entity 129305 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $12.80 | $0.00 |
DisclosureSEC source: 0000899243-17-028504 · doc4.xml · derivative · entry 19 HAWLEY ROGER · CIK 0001257386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires 2025-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on June 18, 2015 and vested in a series of twelve (12) successive, equal monthly installments beginning on June 18, 2015, subject to the Reporting Person's continued service to the company on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.